N-[4-({[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]amino}sulfonyl)phenyl]-2-(pentafluorophenyl)hydrazinecarbothioamide

InChIKey	`XTLIGSXCHIJPDK-UHFFFAOYSA-N`
Compound Name	N-[4-({[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]amino}sulfonyl)phenyl]-2-(pentafluorophenyl)hydrazinecarbothioamide
Canonical SMILES	`NS(=O)(=O)c1nnc(NS(=O)(=O)c2ccc(N/C(S)=N/Nc3c(F)c(F)c(F)c(F)c3F)cc2)s1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	8.82
Source	ChEMBL;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P00918	CA2	Homo sapiens	Human	PF00194	9.2	Ki	ChEMBL
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	9.2	pIC50	TTD_MultiTarget
P00915	CA1	Homo sapiens	Human	PF00194	9.2	Ki	ChEMBL
Q16790	CA9	Homo sapiens	Human	PF00194	7.7	Ki	ChEMBL